Antons Martincuks

701 total citations · 1 hit paper
20 papers, 500 citations indexed

About

Antons Martincuks is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Antons Martincuks has authored 20 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Antons Martincuks's work include PARP inhibition in cancer therapy (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and interferon and immune responses (4 papers). Antons Martincuks is often cited by papers focused on PARP inhibition in cancer therapy (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and interferon and immune responses (4 papers). Antons Martincuks collaborates with scholars based in United States, Germany and Finland. Antons Martincuks's co-authors include Hua Yu, Yijia Li, Chunyan Zhang, Andreas Herrmann, Gerhard Müller‐Newen, Andrea Küster, Qianqian Zhao, Lorna Rodrı́guez-Rodrı́guez, Hildegard Schmitz-Van de Leur and Dirk Fahrenkamp and has published in prestigious journals such as Nature reviews. Cancer, Journal of Cell Science and Frontiers in Immunology.

In The Last Decade

Antons Martincuks

19 papers receiving 499 citations

Hit Papers

STAT proteins in cancer: orchestration of metabolism 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antons Martincuks United States 11 237 201 158 114 45 20 500
Jianming Huang China 13 211 0.9× 106 0.5× 90 0.6× 128 1.1× 37 0.8× 41 450
Youlin Kuang China 13 195 0.8× 116 0.6× 139 0.9× 93 0.8× 40 0.9× 35 490
Monika Zajkowska Poland 14 233 1.0× 230 1.1× 140 0.9× 189 1.7× 39 0.9× 46 550
Laura Mannarino Italy 10 214 0.9× 188 0.9× 119 0.8× 104 0.9× 44 1.0× 24 498
Ruixiu Zhang China 10 272 1.1× 202 1.0× 63 0.4× 138 1.2× 24 0.5× 18 492
Ji‐Yoon Ryu South Korea 10 324 1.4× 180 0.9× 49 0.3× 84 0.7× 32 0.7× 17 486
Jae Ho Lo United States 10 193 0.8× 254 1.3× 159 1.0× 92 0.8× 104 2.3× 29 547
Chengjuan Jin China 13 216 0.9× 79 0.4× 89 0.6× 116 1.0× 28 0.6× 21 420

Countries citing papers authored by Antons Martincuks

Since Specialization
Citations

This map shows the geographic impact of Antons Martincuks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antons Martincuks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antons Martincuks more than expected).

Fields of papers citing papers by Antons Martincuks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antons Martincuks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antons Martincuks. The network helps show where Antons Martincuks may publish in the future.

Co-authorship network of co-authors of Antons Martincuks

This figure shows the co-authorship network connecting the top 25 collaborators of Antons Martincuks. A scholar is included among the top collaborators of Antons Martincuks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antons Martincuks. Antons Martincuks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Rui, Brad J. Nakamura, Yijia Li, et al.. (2025). A Critical Role of Intracellular PD-L1 in Promoting Ovarian Cancer Progression. Cells. 14(4). 314–314.
2.
Martincuks, Antons, Begüm Aydoğan Mathyk, Vaagn Andikyan, et al.. (2025). PARP Inhibitors in Ovarian Cancer: Resistance Mechanisms, Clinical Evidence, and Evolving Strategies. Biomedicines. 13(5). 1126–1126. 3 indexed citations
3.
Martincuks, Antons, Chunyan Zhang, Yijia Li, et al.. (2024). Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer. Journal for ImmunoTherapy of Cancer. 12(4). e007716–e007716. 14 indexed citations
4.
Zhang, Chunyan, Antons Martincuks, Jieun Song, et al.. (2024). Local CpG-Stat3 siRNA treatment improves antitumor effects of immune checkpoint inhibitors. Molecular Therapy — Nucleic Acids. 35(4). 102357–102357. 8 indexed citations
5.
Li, Yijia, Sheng‐Hsuan Chien, Rui Huang, et al.. (2024). A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo. Molecular Therapy. 32(10). 3629–3649. 1 indexed citations
6.
Li, Yijia, Chunyan Zhang, Antons Martincuks, Andreas Herrmann, & Hua Yu. (2023). STAT proteins in cancer: orchestration of metabolism. Nature reviews. Cancer. 23(3). 115–134. 175 indexed citations breakdown →
7.
Ding, Liya, Qiwei Wang, Antons Martincuks, et al.. (2023). STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer. Journal for ImmunoTherapy of Cancer. 11(1). e005627–e005627. 62 indexed citations
8.
Girda, Eugenia, June Y. Hou, David L. Nelson, et al.. (2022). Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer. International Journal of Gynecological Cancer. 32(8). 1032–1038. 8 indexed citations
9.
Ding, Liya, Qiwei Wang, Antons Martincuks, et al.. (2022). 910 STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer. Regular and Young Investigator Award Abstracts. A948–A948. 3 indexed citations
10.
Zhao, Qianqian, Yijia Li, Antons Martincuks, et al.. (2022). Niraparib-induced STAT3 inhibition increases its antitumor effects. Frontiers in Oncology. 12. 966492–966492. 4 indexed citations
11.
Martincuks, Antons, Qianqian Zhao, Stephen Lee, et al.. (2022). STAT3 is a potential therapeutic target in cervical cancer (257). Gynecologic Oncology. 166. S137–S138. 1 indexed citations
12.
Martincuks, Antons, Jieun Song, Chunyan Zhang, et al.. (2021). PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer. Frontiers in Oncology. 11. 724104–724104. 26 indexed citations
13.
Martincuks, Antons, Qianqian Zhao, Chunyan Zhang, et al.. (2020). CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3. Frontiers in Oncology. 10. 589601–589601. 55 indexed citations
14.
Zechendorf, Elisabeth, Ahmed Hallawa, Antons Martincuks, et al.. (2018). Heparan Sulfate Induces Necroptosis in Murine Cardiomyocytes: A Medical-In silico Approach Combining In vitro Experiments and Machine Learning. Frontiers in Immunology. 9. 393–393. 8 indexed citations
15.
Martincuks, Antons, et al.. (2017). Nuclear translocation of STAT3 and NF-κB are independent of each other but NF-κB supports expression and activation of STAT3. Cellular Signalling. 32. 36–47. 31 indexed citations
16.
Martincuks, Antons, Dirk Fahrenkamp, Serge Haan, et al.. (2016). Dissecting functions of the N-terminal domain and GAS-site recognition in STAT3 nuclear trafficking. Cellular Signalling. 28(8). 810–825. 12 indexed citations
17.
Märtin, Lukas, Carsten Peters, Lena Heinbockel, et al.. (2016). The synthetic antimicrobial peptide 19-2.5 attenuates mitochondrial dysfunction in cardiomyocytes stimulated with human sepsis serum. Innate Immunity. 22(8). 612–619. 10 indexed citations
18.
Schumacher, Anne, Bernd Denecke, Till Braunschweig, et al.. (2015). Angptl4 is upregulated under inflammatory conditions in the bone marrow of mice, expands myeloid progenitors, and accelerates reconstitution of platelets after myelosuppressive therapy. Journal of Hematology & Oncology. 8(1). 64–64. 19 indexed citations
19.
Märtin, Lukas, Carsten Peters, Susanne Schmitz, et al.. (2015). Soluble Heparan Sulfate in Serum of Septic Shock Patients Induces Mitochondrial Dysfunction in Murine Cardiomyocytes. Shock. 44(6). 569–577. 32 indexed citations
20.
Martincuks, Antons, et al.. (2014). Consequences of the disease-related L78R mutation for dimerization and activity of STAT3. Journal of Cell Science. 127(Pt 9). 1899–910. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026